Literature DB >> 9202070

Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100.

M M Véniant1, V Pierotti, D Newland, C M Cham, D A Sanan, R L Walzem, S G Young.   

Abstract

All classes of lipoproteins considered to be atherogenic contain apo-B100 or apo-B48. However, there is a distinct paucity of data regarding whether lipoproteins containing apo-B48 or apo-B100 differ in their intrinsic ability to promote the development of atherosclerosis. To address this issue, we compared the extent of atherosclerosis in three groups of animals: apo-E-deficient mice (apo-B+/+apo-E-/-) and apo-E-deficient mice that synthesize exclusively either apo-B48 (apo-B48/48apo-E-/-) or apo-B100 (apo-B100/100apo-E-/-). Mice (n = 25 in each group) were fed a chow diet for 200 days, and plasma lipid levels were assessed throughout the study. Compared with the levels in apo-B+/+apo-E-/- mice, the total plasma cholesterol levels were higher in the apo-B48/48apo-E-/- mice and were lower in the apo-B100/100apo-E-/- mice. However, the ranges of cholesterol levels in the three groups overlapped. Compared with those in the apo-B+/+apo-E-/- mice, atherosclerotic lesions were more extensive in the apo-B48/48apo-E-/- mice and less extensive in the apo-B100/100apo-E-/- mice. Once again, however, there was overlap among the three groups. The extent of atherosclerosis in each group of mice correlated significantly with plasma cholesterol levels. In mice from different groups that had similar cholesterol levels, the extent of atherosclerosis was quite similar. Thus, susceptibility to atherosclerosis was dependent on total cholesterol levels. Whether mice synthesized apo-B48 or apo-B100 did not appear to have an independent effect on susceptibility to atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9202070      PMCID: PMC508178          DOI: 10.1172/JCI119511

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  30 in total

Review 1.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.

Authors:  D Steinberg; S Parthasarathy; T E Carew; J C Khoo; J L Witztum
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

2.  Atherosclerosis susceptibility differences among progenitors of recombinant inbred strains of mice.

Authors:  B Paigen; B Y Ishida; J Verstuyft; R B Winters; D Albee
Journal:  Arteriosclerosis       Date:  1990 Mar-Apr

Review 3.  Application of electron microscopy to the study of plasma lipoprotein structure.

Authors:  T Forte; A V Nichols
Journal:  Adv Lipid Res       Date:  1972

4.  Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins.

Authors:  T Henriksen; E M Mahoney; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1981-10       Impact factor: 11.205

5.  The role of dietary fat and cholesterol in atherosclerosis and lipoprotein metabolism.

Authors:  R W Mahley
Journal:  West J Med       Date:  1981-01

6.  Preferential influx and decreased fractional loss of lipoprotein(a) in atherosclerotic compared with nonlesioned rabbit aorta.

Authors:  L B Nielsen; S Stender; M Jauhiainen; B G Nordestgaard
Journal:  J Clin Invest       Date:  1996-07-15       Impact factor: 14.808

7.  Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.

Authors:  E S Krul; M J Tikkanen; T G Cole; J M Davie; G Schonfeld
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

8.  Human apolipoprotein B-100 heparin-binding sites.

Authors:  K H Weisgraber; S C Rall
Journal:  J Biol Chem       Date:  1987-08-15       Impact factor: 5.157

9.  Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1985-09       Impact factor: 11.205

10.  Variation in susceptibility to atherosclerosis among inbred strains of mice.

Authors:  B Paigen; A Morrow; C Brandon; D Mitchell; P Holmes
Journal:  Atherosclerosis       Date:  1985-10       Impact factor: 5.162

View more
  21 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Effects of Tomato and Soy Germ on Lipid Bioaccumulation and Atherosclerosis in ApoE-/- Mice.

Authors:  Brendon W Smith; Rita J Miller; Kenneth R Wilund; William D O'Brien; John W Erdman
Journal:  J Food Sci       Date:  2015-07-14       Impact factor: 3.167

3.  Hypercholesterolemia Induced Immune Response and Inflammation on Progression of Atherosclerosis in Apob(tm2Sgy) Ldlr(tm1Her)/J Mice.

Authors:  Lakshmi Narasimha Rao; Thiruvelselvan Ponnusamy; Sheena Philip; Rupak Mukhopadhyay; Vijay V Kakkar; Lakshmi Mundkur
Journal:  Lipids       Date:  2015-07-16       Impact factor: 1.880

4.  Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding.

Authors:  J Borén; K Olin; I Lee; A Chait; T N Wight; T L Innerarity
Journal:  J Clin Invest       Date:  1998-06-15       Impact factor: 14.808

Review 5.  Atherosclerotic cardiovascular disease: a review of initiators and protective factors.

Authors:  Mohammed S Ellulu; Ismail Patimah; Huzwah Khaza'ai; Asmah Rahmat; Yehia Abed; Faisal Ali
Journal:  Inflammopharmacology       Date:  2016-01-11       Impact factor: 4.473

6.  Increased intestinal lipid absorption caused by Ire1β deficiency contributes to hyperlipidemia and atherosclerosis in apolipoprotein E-deficient mice.

Authors:  Jahangir Iqbal; Joyce Queiroz; Yan Li; Xian-Cheng Jiang; David Ron; M Mahmood Hussain
Journal:  Circ Res       Date:  2012-05-03       Impact factor: 17.367

Review 7.  Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline.

Authors:  Lars Berglund; John D Brunzell; Anne C Goldberg; Ira J Goldberg; Frank Sacks; Mohammad Hassan Murad; Anton F H Stalenhoef
Journal:  J Clin Endocrinol Metab       Date:  2012-09       Impact factor: 5.958

8.  Lipoprotein clearance mechanisms in LDL receptor-deficient "Apo-B48-only" and "Apo-B100-only" mice.

Authors:  M M Véniant; C H Zlot; R L Walzem; V Pierotti; R Driscoll; D Dichek; J Herz; S G Young
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

Review 9.  Lipoprotein size and susceptibility to atherosclerosis--insights from genetically modified mouse models.

Authors:  Murielle M Véniant; Anne P Beigneux; André Bensadoun; Loren G Fong; Stephen G Young
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

Review 10.  Progression and disruption of advanced atherosclerotic plaques in murine models.

Authors:  Michael E Rosenfeld; Michelle M Averill; Brian J Bennett; Stephen M Schwartz
Journal:  Curr Drug Targets       Date:  2008-03       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.